Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00819026
NCT00819026CompletedNot Applicable

Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors

University of Wisconsin, Madison1 site in 1 country15 target enrollmentStarted: October 2008Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
15
Locations
1
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.

Study Design

Study Type
Observational
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •HCV infected on immunosuppression

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Genetics of Hepatitis C Virus InfectionHepatitis CLiver Disease
NCT00005657National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)870
Completed
Not Applicable
Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV PatientsHepatitis C
NCT00703560University of Texas Southwestern Medical Center72
Completed
Not Applicable
Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected PatientsHIV-HCV Co-infected Patients
NCT01964742Assistance Publique Hopitaux De Marseille68
Recruiting
Not Applicable
Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer DevelopmentHepatitis C Virus Infection
NCT06718530Centro di Riferimento Oncologico - Aviano1,000
Unknown
Not Applicable
Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver DiseaseHepatitis c
NCT03591783Assiut University140